CMS Lifts Sanction on CVS Drug Plan - Analyst Blog


The festive season is bringing good tidings for CVS Caremark Corporation ( CVS ), with the Centers for Medicare and Medicaid Services (CMS) lifting sanctions imposed against the former's SilverScript drug plan aimed at senior citizens. The company can now resume enrolling members for SilverScript effective Jan 1, 2014.

On Jan 15, 2013, CMS had imposed an immediate sanction on SilverScript Part D Prescription Drug Plan, forbidding CVS to market or sell any new drug plans. However, the enrollment suspension applied only to the company's Medicare drug plans and did not include other CVS Caremark plans or coverage.

The ban was imposed following the federal healthcare agency's receipt of complaints regarding enrollment, claims processing and customer call-center operations.

The widespread data system failure resulted in thousands of senior citizens being unable to get their medications on time. The ban was a serious threat for the company as it meant that no new enrollments could take place, though existing SilverScript members could continue with their prescriptions getting filled at CVS retail drug stores.

In the suspension letter, CMS has asked CVS Caremark to undertake remedial actions to address the issues without delay.  Subsequently, CVS Caremark put its best foot forward, making honest attempts to look into the enrollment processing issues to provide customers with improved service and support.

Last week, owing to CVS Caremark's correctional efforts, the company received the permission to start marketing and enrollment in the SilverScript Medicare Part D Prescription Drug Plan (PDP).

CVS Caremark currently has a Zacks Rank #3 (Hold). Better-ranked stocks in the sector include McKesson Corporation ( MCK ) carrying a Zacks Rank #1(Strong Buy), Align Technology Inc. ( ALGN ) and Herbalife Ltd. ( HLF ) each carrying a Zacks Rank #2 (Buy).

ALIGN TECH INC (ALGN): Free Stock Analysis Report

CVS CAREMARK CP (CVS): Free Stock Analysis Report

HERBALIFE LTD (HLF): Free Stock Analysis Report

MCKESSON CORP (MCK): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ, Inc.

This article appears in: Investing , Business , Stocks

Referenced Stocks: ALGN , CMS , CVS , HLF , PDP

More from

Related Videos




Most Active by Volume

  • $10.26 ▼ 6.81%
  • $15.58 ▼ 1.08%
  • $7.13 ▲ 51.06%
  • $112.12 ▲ 2.39%
  • $13.49 ▲ 0.22%
  • $27.86 ▲ 2.50%
  • $5.67 ▼ 0.18%
  • $28.07 ▲ 0.14%
As of 10/9/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by